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ABSTRACT Toxoplasma gondii is an intracellular parasite that reconfigures its host cell
to promote pathogenesis. One consequence of Toxoplasma parasitism is increased mi-
gratory activity of host cells, which facilitates dissemination. Here, we show that Toxo-
plasma triggers the unfolded protein response (UPR) in host cells through calcium re-
lease from the endoplasmic reticulum (ER). We further identify a novel role for the host
ER stress sensor protein IRE1 in Toxoplasma pathogenesis. Upon infection, Toxoplasma
activates IRE1, engaging its noncanonical role in actin remodeling through the binding
of filamin A. By inducing cytoskeletal remodeling via IRE1 oligomerization in host cells,
Toxoplasma enhances host cell migration in vitro and dissemination of the parasite to
host organs in vivo. Our study has identified novel mechanisms used by Toxoplasma to
induce dissemination of infected cells, providing new insights into strategies for treat-
ment of toxoplasmosis.
IMPORTANCE Cells that are infected with the parasite Toxoplasma gondii exhibit
heightened migratory activity, which facilitates dissemination of the infection
throughout the body. In this report, we identify a new mechanism used by Toxo-
plasma to hijack its host cell and increase its mobility. We further show that the abil-
ity of Toxoplasma to increase host cell migration involves not the enzymatic activity
of IRE1 but rather IRE1 engagement with actin cytoskeletal remodeling. Depletion of
IRE1 from infected host cells reduces their migration in vitro and significantly hinders
dissemination of Toxoplasma in vivo. Our findings reveal a new mechanism underly-
ing host-pathogen interactions, demonstrating how host cells are co-opted to
spread a persistent infection around the body.
KEYWORDS Toxoplasma, parasites, UPR, IRE1, PERK, cell migration, filamin A, host-
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Toxoplasma gondii is an obligate intracellular parasite capable of infecting anynucleated cell in warm-blooded vertebrates. Recent studies have revealed a striking
degree of host cell remodeling taking place in Toxoplasma-infected cells that serves to
facilitate pathogenesis and transmission. In addition to secreted parasite effectors that
modulate host cell gene expression, Toxoplasma infection can alter immune responses
and enable dissemination to other host tissues (1). Therein, Toxoplasma can differen-
tiate from the replicative tachyzoites to the latent bradyzoite stage, enabling formation
of tissue cysts that persist for the lifetime of the infected host (2).
Upon host cell invasion, Toxoplasma forms a parasitophorous vacuole (PV) that
serves as a protective niche that can interface with the host cell cytoplasm to sequester
nutrients (3). Curiously, Toxoplasma recruits the host endoplasmic reticulum (ER) to the
PV via association between their respective membranes, although the reasons for this
high-affinity interaction are not yet understood (4, 5).
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The ER is sensitive to the perturbations in protein homeostasis through a stress-
sensing pathway known as the unfolded protein response (UPR). Three ER transmem-
brane proteins, IRE1, ATF6, and PERK, operate as sensors that activate the UPR, leading
to changes in gene expression that restore and expand the processing capacity of the
organelle (6–8). IRE1 (ERN1) is a protein kinase and endoribonuclease that facilitates
cytosolic splicing of XBP1 (XBP1s) mRNA, thereby enhancing expression of the XBP1s
isoform, which induces transcription of genes involved in ER-associated protein deg-
radation (ERAD), lipid synthesis, and protein folding (7, 8). In response to ER stress, ATF6
transits from the ER to the Golgi apparatus, where it is cleaved, releasing an N-terminal
cytosolic fragment (ATF6-N) that enters the nucleus and activates UPR target genes
involved in protein folding and transport (6, 9). PERK (EIF2AK3) is the third UPR sensor,
which phosphorylates the  subunit of eukaryotic initiation factor 2 (eIF2) to direct
translational and transcriptional modes of gene expression that regulate ER processing
of proteins, metabolism, and the oxidation status of cells (6, 10). While the three ER
stress sensory proteins function in parallel, there is cross-regulation that serves to
coordinate the timing and magnitude of the UPR. For example, PERK was reported to
induce expression of RPAP2, which serves to dephosphorylate and repress IRE1, thereby
providing a means for the cell to abort failed ER stress adaptation and trigger apoptosis
(11).
In addition to its role in the UPR, IRE1 was recently shown to modulate cytoskeletal
remodeling and cell migration through direct interactions with the actin cross-linking
factor filamin A (12). The role of IRE1 in cytoskeletal remodeling is enhanced by
pharmacological induction of ER stress but occurs independently of IRE1 protein kinase
and endoribonuclease activities (12); rather, IRE1 serves as a scaffolding protein for
filamin A to orchestrate changes in cellular motility. This is noteworthy because
Toxoplasma stimulates host cell migration, turning its host cell into a “Trojan horse” that
can ferry parasites throughout the body (13). Given the recruitment of host ER to the
PV, we postulated that migratory activities mediated by IRE1 function in parasite
dissemination. In the present study, we uncovered a new mechanism by which
Toxoplasma alters host ER homeostasis to produce hypermigratory activity in infected
host cells. We show that during the course of Toxoplasma infection, the three UPR
sensory proteins in the host cells are activated by a process involving calcium release
from the ER, leading to IRE1 oligomerization, association with filamin A, and enhanced
cell migration. Importantly, the IRE1-associated migration is a crucial determinant for
successful dissemination of toxoplasmosis in a mouse model of infection.
RESULTS
Induction of the UPR in Toxoplasma-infected host cells. It is currently unclear
why intracellular tachyzoites recruit host ER to the parasite PV. To address whether
Toxoplasma perturbs host ER homeostasis, we infected mouse embryonic fibroblasts
(MEFs) with RH strain parasites and measured three primary markers of the host UPR
over a 36-h time course. Within 12 h of infection, Toxoplasma increased activation of
PERK as measured by its self-phosphorylation (PERK-P), induced expression of ATF6 and
formation of its cleavage product ATF6-N, and increased levels of the IRE1-derived
spliced variant of XBP1 (XBP1s) (Fig. 1A). It is noteworthy that whereas expression of
ATF6-N and XBP1s was transient, with increased amounts of the proteins appearing
between 12 and 20 h postinfection (hpi), PERK-P increased throughout the 36 h of
infection (Fig. 1A). These results indicate that Toxoplasma infection causes ER stress that
activates each of the sensory proteins of the UPR, with some differences in the duration
of their induction.
Activation of IRE1 involves oligomerization that can be visualized by a pattern of
punctate spots by IFA (14–16). We expressed enhanced green fluorescent protein
(EGFP)-tagged IRE1 in MEFs that had deletions of the endogenous IRE1 gene by
CRISPR/Cas9 genome editing (see Fig. S1A to C in the supplemental material); upon
Toxoplasma infection, we observed formation of IRE1 foci, which is consistent with
reported IRE1 activation by oligomerization (Fig. 1B) (15, 16). Furthermore, expres-
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sion of XBP1s mRNA, and its downstream target genes involved in ERAD and protein
folding, was induced upon Toxoplasma infection of wild-type (WT) MEFs (Fig. 1C).
These results indicate that IRE1 activation and signaling occur in response to
Toxoplasma infection.
To further study the timing of UPR induction and potential cross-regulation
between the UPR sensors in infected cells, we measured XBP1s mRNA levels by reverse
transcription-quantitative PCR (RT-qPCR) in WT, IRE1/, and PERK/ MEFs. In WT cells,
levels of XBP1s mRNA rose sharply until 18 hpi (Fig. 1D), consistent with the increase in
XBP1s protein (Fig. 1A). As expected, XBP1s mRNA was not detected in infected IRE1/
cells (Fig. 1D). In comparison, there was induced XBP1s mRNA that was sustained
during 36 h of Toxoplasma infection in PERK/ cells, indicating that without PERK,
IRE1 continues to facilitate XBP1s expression (Fig. 1D). These results are consistent
with the idea that PERK governs IRE1 activity, as previously reported (11), and
suggest that in infected WT cells, PERK operates to attenuate the response of IRE1
after 18 hpi.
FIG 1 Toxoplasma infection triggers activation of the UPR in host cells. (A) At the indicated times following
infection with Toxoplasma, cells were harvested and the levels of total PERK, PERK-P, full-length ATF6 and ATF6-N,
XBP1s, and GAPDH were measured by immunoblot analyses. (B) IRE1/ MEFs were transfected with a plasmid
encoding EGFP-IRE1 (green), followed by infection with Toxoplasma. DAPI (blue) was used to visualize host cell and
parasite nuclei. Two boxed areas (1 and 2) of each condition are amplified to highlight the IRE1 distribution.
Bar  5 m. Arrows indicate Toxoplasma infection as based on DAPI staining. (C) MEFs were infected with
Toxoplasma for 18 h, or were mock infected, and the mRNA levels of the indicated ERAD/chaperone genes were
measured by RT-qPCR. Levels of mRNA were normalized to those for mock-infected cells, represented as a value
of 1 (SD; n  3). **, P  0.005; ***, P  0.001; ****, P  0.0001. (D) XBP1s mRNA levels were measured by RT-qPCR
at the indicated times in WT, PERK/, and IRE1/ MEFs, as indicated. Levels of XBP1s mRNA were normalized to
total XBP1 mRNA in mock-infected cells (value of 1) at each time point (SD; n  3). ****, P  0.0001.
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IRE1 affects calcium release from ER in Toxoplasma-infected cells. Protein folding
in the ER is highly sensitive to the concentration of calcium, which is released from the
organelle by ryanodine receptors (RyR) and inositol 1,4,5-triphosphate (IP3) receptors
(IP3R) (17). The ER is a major reservoir of calcium; disruptions of calcium homeostasis
can lead to unfolded proteins and initiation of the UPR (17). To determine whether
calcium content is altered in the host ER during Toxoplasma infection, we first measured
cytosolic calcium in infected MEFs. Over an 18-h period, Toxoplasma infection induced
a steady increase in host cell cytosolic calcium levels (Fig. 2A and Fig. S2A). Basal
calcium levels in the cytosol of IRE1/ cells were lower than in WT cells, as previously
reported (18), with some increase upon parasite infection (Fig. 2A and Fig. S2A). To
assess the mode of calcium release from the host ER during infection, we monitored
calcium transport using fluorescent-4 acetoxymethyl ester (Fluo-4AM) in the presence
of antagonists of RyR or IP3R. The cytosolic calcium levels were lower in infected cells
treated with either antagonist, with the most robust calcium reduction occurring with
inhibition of IP3R (Fig. 2B). We further addressed the contribution of RyR and IP3R to
calcium release by adding increasing doses of caffeine and IP3, agonists of RyR and IP3R
activity (19), respectively, to WT and IRE1/ cells infected with Toxoplasma for 18 h
and incubated with Mag-Fluo-4. To compare calcium release between RyR and IP3R in
WT and IRE1/ cells, the fluorescence values were represented as the percentage of
calcium release and the respective start points were normalized to those for untreated
WT and IRE1/ cells, respectively. The RyR agonist enhanced calcium to similar levels
in infected WT and IRE1/ cells (Fig. 2C). In contrast, the agonist IP3 induced appre-
ciable calcium release only in infected WT cells (Fig. 2D), indicating a role for IRE1 in
regulating IP3R activity, as previously reported (18). Surprisingly, the percentage of
calcium release was higher when IP3R was stimulated than when RyR was stimulated,
demonstrating that Toxoplasma infection differentially alters RyR and IP3R activities.
Collectively, these results suggest that Toxoplasma infection induces significant calcium
release from the host ER by processes involving both IP3R and RyR; this calcium release
FIG 2 Toxoplasma infection induces calcium release. (A) At the indicated time, cytosolic calcium levels
were measured in infected WT and IRE1/ cells. Values of infected cells were normalized to those for
mock-infected cells (SD; n  3). **, P  0.005; ****, P  0.001. (B) Infected WT and IRE1/ cells were
treated with RyR inhibitor (100 M ryanodine) or IP3R inhibitor (0.6 M xestospongin C [XeC]) for 6 h, and
the levels of cytosolic calcium were measured (SD; n  3). **, P  0.05; ***, P  0.005. Infected cells were
incubated with Mag-Fluo-4, followed by plasma membrane permeabilization with saponin and incuba-
tion with ATP to maintain the calcium in the ER. To estimate RyR (C) and IP3R (D) activities, WT and
IRE1/ cells infected with Toxoplasma for 18 h were treated with caffeine or IP3 at the indicated
concentrations; calcium release was represented as fluorescence using Mag-Fluo-4 as described previ-
ously (19). Values are percent calcium release; the respective start points were normalized to those for
untreated WT and IRE1/ cells, respectively (SD; n  3). **, P  0.05; ****, P  0.001.
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is influenced by IRE1 and is a likely contributor to the activation of the host ER stress
sensor proteins shown in Fig. 1A.
IRE1 activation induces cell migration in infected cells. Toxoplasma triggers rapid
morphological changes in host cells, including disappearance of podosome structures
and appearance of lamellipodia (20). IRE1 has recently been shown to have nonca-
nonical functions in actin cytoskeletal remodeling by directly binding to filamin A (12).
To address whether activation of IRE1 by Toxoplasma infection enhances host cell
migration, we quantified the number of lamellipodia per infected cell normalized to the
value for uninfected cells (Fig. 3A and Fig. S3A). At 18 hpi, Toxoplasma infection
increased the number of lamellipodia in WT cells and these structures were significantly
diminished in IRE1-deficient cells (Fig. 3A). There were greater numbers of lamellipodia
in PERK-deficient cells or those treated with a PERK inhibitor, consistent with the idea
that PERK is a negative regulator of IRE1 (Fig. 3A). Of interest, treatment with inhibitors
of IRE1, namely, 48c, which interferes with endoribonuclease activity, and KIRA6,
which blocks IRE1 protein kinase activity, did not change the number of lamellipodia
compared with that in infected cells treated with a vehicle (Fig. 3A). These results
indicate that IRE1 can control migration of Toxoplasma-infected cells independently of
its known enzymatic activities.
The functions of filamin A in cytoskeleton dynamics and cell migration are depen-
dent on phosphorylation of serine 2152 (S2152) (21). We detected a sharp increase in
filamin A phosphorylation in MEFs infected with Toxoplasma for 18 h, which was not
observed in host cells lacking IRE1 (Fig. 3B). To address whether there is an association
between IRE1 and filamin A, we expressed Myc-tagged filamin A (Myc-FLNA) in WT
MEFs. Following 18 h of Toxoplasma infection, we then performed an immunoprecipi-
tation (IP) of the tagged filamin A, followed by immunoblot measurements of associ-
ated IRE1. There was enhanced association of IRE1 with filamin A in cells infected with
the parasite compared to those left uninfected (Fig. 3C).
Next, we measured changes in host cell transmigration upon parasite infection and
determined that there was a 2-fold increase in migration of WT MEFs upon infection
with Toxoplasma (Fig. 3D and Fig. S3B). Increased host cell migration was observed
regardless of whether the cells were infected with type I RH or type II ME49 strain
parasites (Fig. S3C). In contrast, parasite infection did not induce migration of cells
lacking IRE1. Levels of migration in infected WT MEFs treated with one of the IRE1
enzymatic inhibitors, KIRA6 and 48c, or an ATF6 inhibitor (Ceapin-A7) were not
significantly changed compared to those in untreated infected MEFs, nor were they
altered in cells lacking the downstream IRE1 target XBP1 (Fig. 3D and Fig. S3B). Notably,
Toxoplasma-induced migration of PERK-deficient cells or WT cells treated with PERK
inhibitor was increased 2.5-fold upon parasite infection compared to that in infected
cells with functional PERK (Fig. 3D and Fig. S3B). These results suggest that IRE1 plays
a critical role in inducing migration of Toxoplasma-infected cells and that this migration
is independent of the protein kinase and endoribonuclease activities of IRE1 and its
downstream target XBP1. Furthermore, PERK is suggested to dampen both IRE1 func-
tions in XBP1 mRNA splicing and cell migration, which are induced upon Toxoplasma
infection.
ER stress induces cell migration by mechanisms involving IRE1 oligomeriza-
tion. To better understand the mechanisms by which IRE1 enhances host cell migration
in response to Toxoplasma infection, we rescued the IRE1/ cells by expressing WT or
defined mutant versions of IRE1 (Fig. 3E and Fig. S4A). Equal amounts of the IRE1
proteins were expressed as judged by immunoblot and immunofluorescence analyses
(Fig. S4B and C). As expected, ire1-wt rescued the migration capacity of infected cells
(Fig. 3E and Fig. S3D). Expression of IRE1 defective in kinase (ire1-kD) or endoribonu-
clease (ire1-eD) activities still rescued the migration phenotype, further supporting the
idea that these activities are dispensable for induced cell migration in response to
parasite infection (Fig. 3E). In contrast, cells expressing IRE1 with mutations in the
oligomerization domain (ire1-oD) were deficient in Toxoplasma-induced migration
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(Fig. 3E). Furthermore, a truncated version of IRE1 (ire1-965) lacking the proline-rich
carboxy-terminal segment of IRE1 that binds filamin A (12) was also impaired in cell
migration following infection (Fig. 3E). As anticipated, only ire1-wt and ire1-965
showed induction of spliced XBP1 mRNA upon pharmacological induction of ER stress
(Fig. S4D). These results suggest that Toxoplasma infection induces IRE1 oligomeriza-
tion (see also Fig. 1B) and that the hypermigratory behavior of infected host cells is
FIG 3 Activation of IRE1 enhances migration of cells infected with Toxoplasma. (A) The numbers of lamellipodia
were determined in 50 randomly selected MEFs infected with Toxoplasma 18 hpi and normalized to uninfected
cells. Also shown are infected WT cells treated with 1.2 M PERKi (GSK2656157), 0. 4 M 48c, 250 nM KIRA6, or
0.2 M ceapin-A7 for 18 h (SD; n  5). **, P  0.05; ****, P  0.005. ns, not significant. (B) WT and IRE1/ cells
were infected with Toxoplasma for 18 h, and then cells were harvested and the levels of filamin A phosphorylation
(S2152) were measured by immunoblot analyses. (C) WT cells transiently expressing Myc-filamin A were infected
with Toxoplasma for 18 h. IP of the tagged Filamin A was carried out using Myc magnetic beads. Bound proteins
were separated by SDS-PAGE and the levels of Myc-filamin A and associated IRE1 were measured by immuno-
blotting and compared to those in uninfected cells. Densitometry of the IRE1 signal was divided by that of the Myc
signal (IRE1/Myc). (D) WT or IRE1/, PERK/, and XBP1/ cells were infected with Toxoplasma for 18 h.
Alternatively, WT cells were infected with parasites and treated with the following inhibitors during migration per
18 h: 1.2 M PERKi (GSK2656157), 0.2 M Ceapin-A7, 250 nM KIRA6, or 0.4 M 48c. Infected and mock-infected
cells were trypsinized and counted, and the same number of cells was used for the transmigration assay.
Transmigration was determined by counting the number of infected normalized to noninfected cells that migrated
through the membrane under each condition (SD; n  3). ***, P  0.0005. (E) IRE1/ cells were rescued with
ire1-wt (wild type), kD (kinase domain dead; K599A), eD (endoribonuclease domain dead; P830L), oD (oligomer-
ization domain dead; D123P), or 965 (carboxy-terminally truncated 965), and then a transmigration assay was
carried out as described above (SD; n  3). ****, P  0.0001. (F) Transmigration assay of infected WT MEFs was
carried out in the presence of IP3R and RyR inhibitors (0.6 M XeC and 100 M ryanodine [Ry]) or activators (100 M
IP3 and 1 mM caffeine) (SD; n  3). *, P  0.1; **, P  0.05; ***, P  0.0005.
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reliant on both the oligomerization domain and the portion of IRE1 that interacts with
filamin A.
Since we found that Toxoplasma induces calcium release from the host ER upon
infection, we examined the importance of calcium release in host cell migration
induced by Toxoplasma. We treated infected cells with RyR and IP3R blockers or
activators during the migration assay: ryanodine and xestospongin-C (XeC) were used
to inhibit RyR and IP3R, respectively; caffeine and IP3 were used to activate RyR and IP3R,
respectively. When infected cells were treated with the RyR and IP3R activators (releas-
ing calcium from ER into the cytosol), the migration levels increased compared to those
in cells not treated with these agents. In contrast, addition of the IP3R inhibitor
significantly decreased migration of the infected cells (Fig. 3F and Fig. S3E), consistent
with IP3R being the major calcium release receptor involved in triggering the host UPR
following Toxoplasma infection (Fig. 2B). These results support the idea that calcium
release from the host ER contributes to IRE1 activation and its subsequent role in
augmenting migration in response to infection.
IRE1 controls host cell migration in infected immune cells in vitro. Toxoplasma
makes use of immune cells as a “Trojan horse” to disseminate to distal organs and
tissues throughout the body of the infected host (13). To address whether Toxoplasma
targets IRE1 in immune cells to enhance their migration and facilitate dissemination, we
infected bone marrow-derived dendritic cells (DCs) with Toxoplasma. Levels of XBP1s
mRNA were sharply increased upon Toxoplasma infection in DCs (Fig. 4A), consistent
with the idea that the parasite infection activated IRE1 in this cell type. Next, we used
CRISPR/Cas9 and two distinct single guide RNAs (sgRNA1 and -2) to disrupt IRE1 in DCs
(Fig. S5A). sgRNA1 and sgRNA2 decreased IRE1 mRNA levels by 66% and 93%, respec-
tively (Fig. 4B). Each gRNA also led to a corresponding reduction in IRE1 protein in DCs,
with sgRNA2 leading to no detectable IRE1 (Fig. 4C). IRE1-depleted DCs [ire1 ()] did
not exhibit decreased viability compared to that of WT cells, nor did they show any
difference in infectivity with Toxoplasma (Fig. 4D and Fig. S5B). However, loss of IRE1 in
DCs significantly lowered the transmigratory capacity following infection with either
type I or type II strains of Toxoplasma (Fig. 4E and Fig. S5C and D). To determine
whether IP3R plays a role in the migration of infected DCs, we carried out the migration
assay in the presence of XeC. Inhibition of IP3R resulted in a loss of host cell migration
following 18 h of Toxoplasma infection (Fig. 4F and Fig. S5E), further supporting the
importance of calcium homeostasis in the ER for migration of Toxoplasma-infected cells.
To test whether IRE1 controls the migration of infected macrophages as well, we used
CRISPR/Cas9 to deplete IRE1 in J774.1 macrophages (Fig. 4G and H). As observed for
DCs, the loss of IRE1 significantly reduced the ability of infected macrophages to
migrate (Fig. 4I and Fig. S5F).
IRE1 facilitates dissemination of Toxoplasma in vivo. To determine the impor-
tance of IRE1 in the migration of infected DCs in vivo, we inoculated C57BL/6 mice
intraperitoneally (i.p.) with infected WT or infected ire1 () DCs and measured parasite
burden in the spleen by PCR at various intervals over 3 days. Depletion of IRE1 in the
DCs by CRISPR/Cas9 was confirmed by RT-qPCR and immunoblot analyses (Fig. 5A and
B). Moreover, we ascertained that the depletion of IRE1 in DCs had no significant effect
on parasite infectibility or replication rate (Fig. 5C and Fig. S5G). Toxoplasma was first
detected in the spleens of mice 12 h following i.p. inoculation with infected WT DCs,
increasing at each time point over the 3-day period (Fig. 5D). In striking contrast,
appreciable levels of Toxoplasma dissemination of infected IRE1-depleted DCs to the
spleen were not detected until 3 days following inoculation of the mice (Fig. 5D). Even
at the 3-day point, the loss of IRE1 from DCs produced lowered levels of parasitemia in
the spleen that were similar to those measured at 12 h for infected WT DCs. We also
measured Toxoplasma dissemination to the brain at 3 days, finding 200-fold fewer
parasites when infected IRE1-depleted DCs were inoculated into the mice (Fig. 5E). Mice
inoculated with infected DCs lacking IRE1 survived significantly longer than mice
receiving infected WT DCs (Fig. 5F). These results demonstrate a novel role for host IRE1
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in parasite pathogenesis, as IRE1 is crucial for the migration of immune cells being
co-opted as Trojan horses for parasite dissemination.
DISCUSSION
Obligate intracellular pathogens create a niche inside their host cell that allows for
parasite protection, nutrient acquisition, and the controlled release of pathogen effec-
tors that promote infection and dissemination. Toxoplasma tachyzoites reside inside a
nonfusogenic parasitophorous vacuole (PV) that forms intimate contacts with host
organelles and vesicles, including the ER and mitochondria (4, 5). It is suggested that
the recruitment of host organelles to the PV allows Toxoplasma to control critical host
cell operations, including antigen presentation, nutrient production, and suppression of
apoptosis (5). In this study, we addressed the consequences of the Toxoplasma-ER
engagement on parasite infection and dissemination in the host. As illustrated in a
FIG 4 IRE1 is important for migration of infected DCs. (A) Bone marrow-derived DCs were infected with
Toxoplasma for 18 h and XBP1s mRNA levels were measured by RT-qPCR. The values of XBP1 transcripts
were normalized to values of total XBP1 (SD; n  3). ***, P  0.0005. (B and C) The CRISPR/Cas9-
engineered depletion of IRE1 in DCs, designated ire1 (), was assayed by RT-qPCR and immunoblotting
using IRE1 antibody compared to WT cells (GAPDH was included as a loading control). (D) Percent
infection was determined by counting the number of parasites inside 100 WT or ire1 () cells. (E) WT and
ire1 () cells were infected for 18 h and the transmigration assay was carried out for 6 h. Transmigration
was determined by counting the number of infected cells normalized to that of uninfected cells (SD;
n  3). **, P  0.05; ***, P  0.0005. (F) WT DCs were infected for 18 h and the transmigration assay was
carried out in the presence of 0.6 M xestospongin C (XeC) for 6 h (SD; n  3). ***, P  0.001. (G and
H) J774.1 macrophages were transfected with sgRNA2 and the depletion of IRE1 was assayed by RT-qPCR
and immunoblotting as described for panel C. (I) At 18 hpi, WT or ire1 () J774.1 macrophages were
assayed for transmigration as described above (SD; n  3). **, P  0.05.
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model presented in Fig. 5G, we showed that Toxoplasma infection activates each of the
UPR sensor proteins, including IRE1, via ER stress that results at least in part from release
of calcium from the organelle, primarily through IP3R. In addition to its role in the UPR,
IRE1 has recently been shown to have noncanonical functions associated with the
remodeling of the cytoskeleton through direct interactions with the actin cross-linking
factor filamin A (12). We showed that Toxoplasma alters the morphology of its host cells
through IRE1-filamin A interactions, which directs cytoskeletal remodeling that contrib-
utes to a hypermigratory phenotype that facilitated dissemination of the parasite into
multiple organs of the infection host. The role of IRE1 in Toxoplasma-induced hyper-
migration is not reliant on its protein kinase or endoribonuclease activities that are
central for classical UPR signaling; rather, it is IRE1 oligomerization and the carboxy-
FIG 5 IRE1 facilitates migration of infected DCs in vivo. (A and B) IRE1 was depleted in bone
marrow-derived DCs by CRISPR/Cas9, and loss of IRE1 expression was assayed by RT-qPCR and immu-
noblot analyses. (C) WT or ire1 () DCs were infected for 18 h, and the percent infection was determined
by counting the number of parasites in 100 cells. (D) Infected WT and ire1 () cells were inoculated into
mice by intraperitoneal (i.p.) injection (106 infected cells); mice infected i.p. with free tachyzoites in sterile
PBS (RH strain) are designated “Toxoplasma.” At the indicated hpi, the spleen of each mouse was
harvested, and the number of parasites was determined by PCR. ***, P  0.005; ****, P  0.0001. (E) At
3 days postinoculation, the number of parasites in the brain was determined using PCR. ****, P  0.0001.
(F) Survival of C57BL/6 mice challenged with 106 infected WT or ire 1 () DCs. ***, P  0.0005. Statistical
analyses were done by Gehan-Breslow-Wilcoxon test. (G) Model for IRE1 direct hypermigration of host
cells infected by Toxoplasma. During infection, Toxoplasma triggers calcium release from the host ER,
which creates ER stress and induction of the UPR, which results in enhanced IRE1 association with filamin
A. Consequently, the IRE1-filamin A interaction promotes actin remodeling and host cell migration.
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terminal residues required for filamin A association that prove to be important. Further
mechanistic details into how ER recruitment to the PV elicits host UPR remain to be
resolved.
After oral infection, Toxoplasma rapidly spreads from the lamina propria to distal
organs using host immune cells as a vehicle for dissemination (22). Given our discovery
that IRE1 is mobilized by Toxoplasma to enhance hypermigratory behavior in host cells,
we tested whether IRE1 is crucial to in vivo dissemination in a mouse model of infection.
We found that depletion of IRE1 in immune cells sharply decreases the number of
parasites in the spleens or brains of infected mice (Fig. 5E). These results reveal a
number of potential new targets for drug development aimed at thwarted spread of
infection in the body.
It is noteworthy that other mechanisms have been suggested to contribute to the
cell hypermotility upon Toxoplasma infection. For example, parasite effector protein
TgWIP, TIMP-1, and GABAergic signaling was reported to signal hypermigration of
certain infected host cells (23–26). A key question for future studies is how these
different mechanisms are coordinated to induce hypermigratory activity in Toxoplasma-
infected host cells.
MATERIALS AND METHODS
Host cell and parasite culture. Mouse embryonic fibroblasts (MEFs) were cultured in Dulbecco’s
modification of Eagle’s medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum
(FBS) (Gibco/Invitrogen) and penicillin-streptomycin at 37°C with 5% CO2. PERK/ cells were previously
reported (27), and IRE1-deficient MEFs were engineered by CRISPR as described below. Host cells were
seeded at a density of 2  105/well in a 6-well plate and cultured for 18 h. Infection was performed using
a multiplicity of infection (MOI) of 3 with type I or II (RH or ME49) strain Toxoplasma parasites for 18 h.
The infected cells were cultured in DMEM supplemented with 10% heat-inactivated FBS (Gibco/
Invitrogen) and penicillin-streptomycin at 37°C with 5% CO2. Cultures of DCs and J774.1 macrophages
were cultivated in RPMI medium supplemented with 10% heat-inactivated FBS (Gibco/Invitrogen) and
penicillin-streptomycin at 37°C with 5% CO2 and infected as described above.
Generation of IRE1 knockout cells. Disruption of the IRE1 gene in MEFs was carried out using the
CRISPR/Cas9 method (28). Two distinct sgRNAs designed using DESKGEN toll (g1-TGGACACGGAGCT
GACT and g2-ACACGGAGCTGACTGGG) were examined individually. The sgRNAs were prepared using the
EnGen sgRNA synthesis kit (New England BioLabs), along with an sg control (g-control-CATCCTCGGCA
CCGTCACCC). The sgRNAs were then associated with EnGen Spy Cas9 NLS protein (New England BioLabs)
at room temperature for 20 min. MEFs were then transfected with the bound sgRNA/Cas9 protein using
the Lipofectamine CRISPRMAX Cas9 transfection reagent (Thermo Fisher Scientific). After culturing the
transfected cells for 48 h, 100 cells were plated in 10-mm tissue-culture dishes for cloning. Cloned
IRE1/ MEFs were validated by RT-qPCR using specific primers and by immunoblotting using IRE1-
specific antibody (Abcam; ab37073). IRE1/ cells were complemented with pcDNA3-derived vectors
containing WT or mutant versions of IRE1. Briefly, the mouse cDNA sequence of IRE1 from MEFs was
inserted into pcDNA3-EGFP plasmid (Addgene; number 13031), resulting in fusion proteins with EGFP
fused to the carboxy terminus of IRE1. Mutations in IRE1 include changes inactivating the critical
functions, including kD (kinase domain; K599A), eD (endoribonuclease domain; P830L), oD (oligomeriza-
tion domain; D123P), and c-terminal (carboxy-terminally truncated Δ965), were carried out using specific
primers (Table S1) and the Q5 site-directed mutagenesis kit (New England BioLabs). After sequence
verification, the plasmids were transfected into IRE1/ cells using FuGENE 6 transfection reagent.
Rescued WT and mutant IRE1 protein expression were confirmed by immunoblotting and immunoflu-
orescence microscopy (Fig. S4A to C).
To generate bone marrow-derived dendritic cells (DCs), 10  106 bone marrow cells were isolated
and cultured in a 6-well plate in 3 ml of complete medium (RPMI 1640 medium supplemented with 10%
fetal bovine serum, penicillin, streptomycin, glutamine, 2-mercaptoethanol, 20 ng/ml of granulocyte-
macrophage colony-stimulating factor [GM-CSF], and 5 ng/ml of interleukin 4 [IL-4] [both from Pepro-
tech]) for 7 days. Half of the medium was replaced every 2 days with medium supplemented with
GM-CSF and IL-4, as previously described (29). DCs or J774.1 macrophages were transfected with
IRE1-sgRNA1 or -2, associated with EnGen Spy Cas9 NLS protein (New England BioLabs), using the
4D-Nucleofector system (Lonza) in combination with the P3 Primary Cell 4D-Nucleofector X kit. After 48
h, the IRE1 mRNA and protein levels were measured by RT-qPCR and immunoblotting, respectively.
Viability of DCs was examined by trypan blue staining.
Measurement of mRNA levels. Cells were first infected with Toxoplasma for 2 h, washed with
phosphate-buffered saline (PBS), and then cultured in DMEM at the desired time points. RNA was isolated
from cells using TRIzol LS reagent (Invitrogen), the cDNA was then generated using Omniscript (Qiagen),
and RT-qPCR was performed using SYBR green real-time PCR master mixes (Invitrogen) and the
StepOnePlus real-time system (Applied Biosystems). Oligonucleotide primers used to measure each
target mRNA are listed in Table S1. Relative levels of transcripts were calculated with the threshold cycle
(CT) method using genes encoding glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and -actin
as internal controls, and then the relative levels of target mRNAs from the mock-infected samples were
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adjusted to 1 and served as the basal control value. Values of each time point were normalized to mock
infection. Each experiment was performed three times, each with three technical replicates.
Immunoblot analyses. Cells were infected with Toxoplasma for 2 h, washed with PBS, and then
cultured in DMEM for the desired times. The infected cells were harvested in radioimmunoprecipitation
assay (RIPA) buffer solution supplemented with cOmplete, EDTA-free protease inhibitor cocktail (Roche).
Protein quantification was performed using Bradford reagent (Sigma-Aldrich). Equal amounts of protein
lysates were separated by SDS-PAGE, and proteins were transferred to nitrocellulose filters. Immunoblot
analyses were done using primary antibodies against IRE1 (Abcam; ab37073), XBP1s (Cell Signaling;
number D2C1F), ATF6 (30), GAPDH (Abcam; ab9485), and PERK (Cell Signaling; number 3192), followed
by Amersham ECL horseradish peroxidase (HRP)-conjugated secondary antibody. These antibodies and
additional reagents used in the study are listed in Table S2. Proteins in the immunoblots were visualized
using FluorChem M (multiplex fluorescence; Protein Simple). Immunoblot analyses were carried out for
three independent experiments.
Calcium measurement assay. Toxoplasma-infected MEFs were washed twice with buffer A solution
supplemented with glucose (120 mM NaCl, 20 mM HEPES [pH 7.4], 4.7 mM KCl, 1.2 mM NaH2PO4, 1.2 mM
MgSO4, 1.2 mM CaCl2, and 10 mM glucose) (31), and then a final concentration of 5 M Fluo-4AM
(Thermo Fisher Scientific; F14201) was added for 15 min at 37°C. Prior to the calcium measurements, cells
were washed once with buffer A solution supplemented with glucose. A Synergy (BioTek) plate reader
was used to monitor the Fluo-4AM fluorescence at 488-nm excitation and 524-nm emission wavelengths.
Values derived from infected cells (F) were divided by the resting intracellular calcium (Fo), ΔF/Fo, and
the values of each time point were normalized to the value for mock-infected cells. In parallel, live
infected cells were imaged by microscopy at the same exposure and a heat map was generated using
ImageJ software. To determine the activity of RyR and IP3R, infected cells were incubated with 5 M
Mag-Fluo-4, a low-affinity Ca2	 indicator, and then permeabilized with 10 g/ml of saponin followed by
incubation with 1.5 mM ATP to maintain Mag-Fluo-4 in the ER (19) (Fig. S2B). Infected cells were treated
with the desired concentrations of caffeine (RyR, 0 to 200 mM) or IP3 (IP3R, 0 to 3 M) (Sigma-Aldrich).
A Synergy (BioTek) plate reader was used to monitor the Mag-Fluo-4 fluorescence at 490-nm excitation
and 525-nm emission wavelengths (19). Values were normalized to those of mock-infected cells.
Immunofluorescence assay. Cultured cells were infected with Toxoplasma for 18 h, then fixed with
2.5% paraformaldehyde for 20 min, and blocked with PBS supplemented with 2% bovine serum albumin
(BSA). Cells were permeabilized in blocking solution containing 0.01% Triton X-100 for 30 min and
incubated with primary antibody (SAG1-p30; Invitrogen) for 1 h. Secondary goat anti-rabbit Alexa Fluor
488 (Invitrogen) was applied for 1 h in the presence of rhodamine phalloidin (Thermo Fisher Scientific)
followed by Prolong gold antifade reagent (Invitrogen). 4=,6-Diamidino-2-phenylindole (DAPI) was used
to visualize host cells and parasite nuclei (Vector Labs). Images were acquired with a Leica inverted
DMI6000B microscope with a 63 oil immersion objective and analyzed in ImageJ. Alternatively, IRE1/
cells were transfected with pcDNA3 encoding IRE1 fused with EGFP at the carboxy terminus and infected
with Toxoplasma for 18 h (MOI, 3); the cells were then fixed and imaged as described above.
Immunoprecipitation assay. The mouse cDNA sequence of filamin A from MEFs was amplified and
cloned into pcDNA3-myc plasmid (Addgene). The resulting plasmid, pcDNA3-myc-FLNA, was transiently
transfected in MEFs, and then the transfected cells were infected with Toxoplasma for 18 h (MOI, 3). Cell
lysates were prepared using IP-lysis solution (0.5% NP-40, 250 mM NaCl, 30 mM Tris, 0.5% glycerol
[pH 7.4], 250 mM phenylmethylsulfonyl fluoride [PMSF] supplemented with cOmplete, EDTA-free pro-
tease inhibitor cocktail [Roche]). To immunoprecipitate Myc-tagged filamin A (Myc-filamin A), equal
amounts of protein lysates were incubated with IgG magnetic beads (Pierce) for 2 h and then mixed with
anti-Myc magnetic beads (Pierce) overnight at 4°C with rotation. Proteins bound to the beads were
subsequently washed four times with IP-lysis solution at 4°C and then once with IP-lysis solution
supplemented with 500 mM NaCl. Protein complexes were eluted at 95°C for 5 min in loading buffer
solution and then separated by SDS-PAGE, followed by immunoblot analyses using specific antibodies to
IRE1 (Abcam; ab37073) or Myc (Cell Signaling; no. 2276).
Cell migration assay. Cells were infected with Toxoplasma at an MOI of 3 for 18 h and then
trypsinized and counted using a hemocytometer; 2  104 cells were resuspended in serum-free medium
and applied to the top of a membrane coated with collagen I (rat tail) (Gibco; A1048301). Transmigration
assays were carried out using a Corning Transwell Costar apparatus (6.5-mm diameter and 8-m pore
size) as described previously (32). After 18 h for MEFs and 6 h for DCs and macrophages, the medium was
removed, and the cells were fixed with 2.5% paraformaldehyde for 20 min. To facilitate counting of
migrated cells, cells that did not migrate and remained on the upper side of membrane (unmigrated
cells) were removed with a swab. The membrane was incubated with Prolong gold antifade reagent with
DAPI. Cells were counted using a Leica inverted DMI6000B microscope with a 63 oil immersion
objective. The transmigration was determined by numbers of migrated infected cells in 5 fields
normalized to number of uninfected cells in each cell type and treatment. Each transmigration assay was
carried out in technical triplicate (n  3).
In vivo migration assay. DCs were plated in 6-well plates (1  106 cells/well) and allowed to adhere
overnight. DCs were infected with Toxoplasma for 1 h (MOI, 3) and then washed with RPMI medium to
remove extracellular parasites. After 18 h, infected DCs were incubated with CellTracker Orange CMTMR
(Thermo Fisher) as described previously (33). Infected DCs were intraperitoneally inoculated into 6-week-
old female C57BL/6J mice whose spleens and brains were subsequently harvested at the indicated time
points. DC migration to the spleen was measured by fluorescence intensity using a Synergy (BioTek) plate
reader at excitation and emission wavelengths of 541 and 565 nm (Fig. S5H). Also, DNA was isolated from
the spleen and brain using TRIzol (Thermo Fisher), and the number of parasites was determined by using
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a PCR-based method measuring levels of the parasite-specific gene region B1 as previously described
(34). After 3 days, the mice were observed twice a day and percent survival was recorded at each time
point. The mouse experiments, including parasite measurement by B1, were performed blinded. The
mice used in this study were housed in American Association for Accreditation of Laboratory Animal Care
(AAALAC)-approved facilities at the Indiana University School of Medicine Laboratory Animal Research
Center (LARC). The Institutional Animal Care and Use Committee (IACUC) at Indiana University School of
Medicine approved the use of all animals and procedures (IACUC protocol number 11376).
Quantification and statistical analysis. Quantitative data are presented as means and standard
deviations and were derived from three biological replicates. Statistical significance was determined
using one-way analysis of variance (ANOVA) with Tukey’s post hoc test and multiple two-tailed t test
using Graph Prism software. The number of biological replicates and P values are indicated in figure
legends. For immunoblot analyses, the reported images are representative of at least three independent
experiments. The mouse survival curve was analyzed by Gehan-Breslow-Wilcoxon test for in vivo analysis.
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